PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Bioinformatics Department, The Cyprus Institute of Neurology and Genetics, Cyprus.\', \'The Cyprus School of Molecular Medicine, Cyprus.\', \'Neurogenetics Department, The Cyprus Institute of Neurology and Genetics, Cyprus.\', \'Laboratory of Pharmacology, Faculty of Medicine, Democritus University of Thrace, Greece.\', \'Institute for Fundamental Biomedical Research, BSRC \'Alexander Fleming\', Vari, Greece.\', \'Neuroepidemiology Department, The Cyprus Institute of Neurology and Genetics, Cyprus.\', \'Cancer Genetics, Therapeutics … Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Cyprus.\', \'Neuroimmunology Department, The Cyprus Institute of Neurology and Genetics, Cyprus.\', \'Department of Molecular Virology, The Cyprus Institute of Neurology and Genetics, Cyprus.\', \'Medical School, University of Nicosia, Cyprus.\', \'University Hospitals Bristol and Weston NHS Foundation Trust, United Kingdom.\', \'Experimental Pharmacology Laboratory, Medical School, University of Cyprus, Cyprus.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • bbab11410.1093/bib/bbab114
?:hasPublicationType
?:journal
  • Briefings in bioinformatics
is ?:pmid of
?:pmid
?:pmid
  • 34009288
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.505
?:rankingScore_hIndex
  • 83
?:title
  • Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all